Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • REGN vs GSK✓SelectedUSD · GSKREGN vs GSK performance historyLatest closeAs of-0.19%11/20
Stock and ETF performance explorer

REGN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+44.5%
GSK return
+40.7%
Excess return
+3.9%
Maximum drawdown
-59.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.2%-0.1%-0.1%-0.1%
7D-3.5%-5.3%+1.8%-1.6%
30D+14.4%-3.7%+18.1%+15.8%
3M+11.5%-7.3%+18.7%+14.4%
6M+42.0%-4.2%+46.2%+43.8%
YTD+19.9%+0.9%+19.0%+19.0%
1Y+25.5%+7.3%+18.3%+22.1%
3Y+16.1%+52.7%-36.7%-1.7%
All+44.5%+40.7%+3.9%+21.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling